Ault Milton C III's Form 4 filing
Alzamend Neuro, Inc. (ALZN) · filed Sep 30, 2025
- Accession no.
- 0001214659-25-014420
- Filed
- Sep 30, 2025
- Trade date
- Sep 26-30, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $184.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ault Milton C IIICIK 0001212502 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 26, 2025 | Common Stock | SSaleDisposed | −37,738 | $2.31 | −$87,174.78 | 73,516 | Indirect | |
| Sep 29, 2025 | Common Stock | SSaleDisposed | −38,324 | $2.31 | −$88,528.44 | 35,192 | Indirect | |
| Sep 30, 2025 | Common Stock | SSaleDisposed | −3,566 | $2.33 | −$8,308.78 | 31,626 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.